The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement)

M.W. Louie-Johnsun, M.M. Handmer, R.J.S. Calopedos, C. Chabert, Ronnie Cohen, T.R.J. Gianduzzo, P.A. Kearns, D.A. Moon, J. Ooi, T. Shannon, D. Sofield, A.H.H. Tan

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    © 2016 The Authors BJU International © 2016 BJU International Published by John Wiley & Sons LtdObjectives: To analyse the Australian experience of high-volume Fellowship-trained Laparoscopic Radical Prostatectomy (LRP) surgeons. Materials and Methods: 2943 LRP cases were performed by nine Australian surgeons. The inclusion criteria were a prospectively collected database with a minimum of 100 consecutive LRP cases. The surgeons’ LRP experience commenced at various times from July 2003 to September 2009. Data were analysed for demographic, peri-operative, oncological and functional outcomes. Results: The mean age of patients were 61.5 years and mean preoperative PSA 7.4 ng/ml. Mean operating time was 168 minutes with conversion to open surgery in 0.5% and a blood transfusion rate of 1.1%. Overall mean length of stay was 2.5 days. 73.6% of pathological specimens were pT2 and 86.3% had Gleason Score >7. Overall positive surgical margins (PSM) occurred in 15.9% with pT2 PSM 9.8%, pT3a PSM 30.8% and pT3b PSM 39.2%. Mean urinary continence at 12 months was 91.4% (data available from five surgeons). Mean 12 months potency after bilateral nerve spare was 47.2% (data available from four surgeons). Biochemical recurrence occurred in 10.6% (mean follow up 17 months). Conclusion: The Australian experience of Fellowship trained surgeons performing LRP demonstrates favourable peri-operative, oncological and functional outcomes in comparison to published data for open, laparoscopic and robotic assisted radical prostatectomy. In our Australian centres, LRP remains an acceptable minimally invasive surgical treatment for prostate cancer despite the increasing use of robotic assisted surgery.
    Original languageEnglish
    Pages (from-to)43-48
    JournalBJU International
    Volume118
    DOIs
    Publication statusPublished - 2016

    Fingerprint

    Robotics
    Prostatectomy
    Conversion to Open Surgery
    Neoplasm Grading
    Nuclear Family
    Blood Transfusion
    Surgeons
    Length of Stay
    Prostatic Neoplasms
    Demography
    Databases
    Recurrence
    Margins of Excision

    Cite this

    Louie-Johnsun, M. W., Handmer, M. M., Calopedos, R. J. S., Chabert, C., Cohen, R., Gianduzzo, T. R. J., ... Tan, A. H. H. (2016). The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement). BJU International, 118, 43-48. https://doi.org/10.1111/bju.13610
    Louie-Johnsun, M.W. ; Handmer, M.M. ; Calopedos, R.J.S. ; Chabert, C. ; Cohen, Ronnie ; Gianduzzo, T.R.J. ; Kearns, P.A. ; Moon, D.A. ; Ooi, J. ; Shannon, T. ; Sofield, D. ; Tan, A.H.H. / The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement). In: BJU International. 2016 ; Vol. 118. pp. 43-48.
    @article{a483d4f4c5694c529651fe9e05bfddd4,
    title = "The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement)",
    abstract = "{\circledC} 2016 The Authors BJU International {\circledC} 2016 BJU International Published by John Wiley & Sons LtdObjectives: To analyse the Australian experience of high-volume Fellowship-trained Laparoscopic Radical Prostatectomy (LRP) surgeons. Materials and Methods: 2943 LRP cases were performed by nine Australian surgeons. The inclusion criteria were a prospectively collected database with a minimum of 100 consecutive LRP cases. The surgeons’ LRP experience commenced at various times from July 2003 to September 2009. Data were analysed for demographic, peri-operative, oncological and functional outcomes. Results: The mean age of patients were 61.5 years and mean preoperative PSA 7.4 ng/ml. Mean operating time was 168 minutes with conversion to open surgery in 0.5{\%} and a blood transfusion rate of 1.1{\%}. Overall mean length of stay was 2.5 days. 73.6{\%} of pathological specimens were pT2 and 86.3{\%} had Gleason Score >7. Overall positive surgical margins (PSM) occurred in 15.9{\%} with pT2 PSM 9.8{\%}, pT3a PSM 30.8{\%} and pT3b PSM 39.2{\%}. Mean urinary continence at 12 months was 91.4{\%} (data available from five surgeons). Mean 12 months potency after bilateral nerve spare was 47.2{\%} (data available from four surgeons). Biochemical recurrence occurred in 10.6{\%} (mean follow up 17 months). Conclusion: The Australian experience of Fellowship trained surgeons performing LRP demonstrates favourable peri-operative, oncological and functional outcomes in comparison to published data for open, laparoscopic and robotic assisted radical prostatectomy. In our Australian centres, LRP remains an acceptable minimally invasive surgical treatment for prostate cancer despite the increasing use of robotic assisted surgery.",
    author = "M.W. Louie-Johnsun and M.M. Handmer and R.J.S. Calopedos and C. Chabert and Ronnie Cohen and T.R.J. Gianduzzo and P.A. Kearns and D.A. Moon and J. Ooi and T. Shannon and D. Sofield and A.H.H. Tan",
    year = "2016",
    doi = "10.1111/bju.13610",
    language = "English",
    volume = "118",
    pages = "43--48",
    journal = "British Journal of Urology International",
    issn = "1464-410X",
    publisher = "John Wiley & Sons",

    }

    Louie-Johnsun, MW, Handmer, MM, Calopedos, RJS, Chabert, C, Cohen, R, Gianduzzo, TRJ, Kearns, PA, Moon, DA, Ooi, J, Shannon, T, Sofield, D & Tan, AHH 2016, 'The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement)' BJU International, vol. 118, pp. 43-48. https://doi.org/10.1111/bju.13610

    The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement). / Louie-Johnsun, M.W.; Handmer, M.M.; Calopedos, R.J.S.; Chabert, C.; Cohen, Ronnie; Gianduzzo, T.R.J.; Kearns, P.A.; Moon, D.A.; Ooi, J.; Shannon, T.; Sofield, D.; Tan, A.H.H.

    In: BJU International, Vol. 118, 2016, p. 43-48.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement)

    AU - Louie-Johnsun, M.W.

    AU - Handmer, M.M.

    AU - Calopedos, R.J.S.

    AU - Chabert, C.

    AU - Cohen, Ronnie

    AU - Gianduzzo, T.R.J.

    AU - Kearns, P.A.

    AU - Moon, D.A.

    AU - Ooi, J.

    AU - Shannon, T.

    AU - Sofield, D.

    AU - Tan, A.H.H.

    PY - 2016

    Y1 - 2016

    N2 - © 2016 The Authors BJU International © 2016 BJU International Published by John Wiley & Sons LtdObjectives: To analyse the Australian experience of high-volume Fellowship-trained Laparoscopic Radical Prostatectomy (LRP) surgeons. Materials and Methods: 2943 LRP cases were performed by nine Australian surgeons. The inclusion criteria were a prospectively collected database with a minimum of 100 consecutive LRP cases. The surgeons’ LRP experience commenced at various times from July 2003 to September 2009. Data were analysed for demographic, peri-operative, oncological and functional outcomes. Results: The mean age of patients were 61.5 years and mean preoperative PSA 7.4 ng/ml. Mean operating time was 168 minutes with conversion to open surgery in 0.5% and a blood transfusion rate of 1.1%. Overall mean length of stay was 2.5 days. 73.6% of pathological specimens were pT2 and 86.3% had Gleason Score >7. Overall positive surgical margins (PSM) occurred in 15.9% with pT2 PSM 9.8%, pT3a PSM 30.8% and pT3b PSM 39.2%. Mean urinary continence at 12 months was 91.4% (data available from five surgeons). Mean 12 months potency after bilateral nerve spare was 47.2% (data available from four surgeons). Biochemical recurrence occurred in 10.6% (mean follow up 17 months). Conclusion: The Australian experience of Fellowship trained surgeons performing LRP demonstrates favourable peri-operative, oncological and functional outcomes in comparison to published data for open, laparoscopic and robotic assisted radical prostatectomy. In our Australian centres, LRP remains an acceptable minimally invasive surgical treatment for prostate cancer despite the increasing use of robotic assisted surgery.

    AB - © 2016 The Authors BJU International © 2016 BJU International Published by John Wiley & Sons LtdObjectives: To analyse the Australian experience of high-volume Fellowship-trained Laparoscopic Radical Prostatectomy (LRP) surgeons. Materials and Methods: 2943 LRP cases were performed by nine Australian surgeons. The inclusion criteria were a prospectively collected database with a minimum of 100 consecutive LRP cases. The surgeons’ LRP experience commenced at various times from July 2003 to September 2009. Data were analysed for demographic, peri-operative, oncological and functional outcomes. Results: The mean age of patients were 61.5 years and mean preoperative PSA 7.4 ng/ml. Mean operating time was 168 minutes with conversion to open surgery in 0.5% and a blood transfusion rate of 1.1%. Overall mean length of stay was 2.5 days. 73.6% of pathological specimens were pT2 and 86.3% had Gleason Score >7. Overall positive surgical margins (PSM) occurred in 15.9% with pT2 PSM 9.8%, pT3a PSM 30.8% and pT3b PSM 39.2%. Mean urinary continence at 12 months was 91.4% (data available from five surgeons). Mean 12 months potency after bilateral nerve spare was 47.2% (data available from four surgeons). Biochemical recurrence occurred in 10.6% (mean follow up 17 months). Conclusion: The Australian experience of Fellowship trained surgeons performing LRP demonstrates favourable peri-operative, oncological and functional outcomes in comparison to published data for open, laparoscopic and robotic assisted radical prostatectomy. In our Australian centres, LRP remains an acceptable minimally invasive surgical treatment for prostate cancer despite the increasing use of robotic assisted surgery.

    U2 - 10.1111/bju.13610

    DO - 10.1111/bju.13610

    M3 - Article

    VL - 118

    SP - 43

    EP - 48

    JO - British Journal of Urology International

    JF - British Journal of Urology International

    SN - 1464-410X

    ER -